Treatment of Lateral Epicondylalgia With Shock Waves
Radial Shock Waves Versus Focal Shock Waves in the Treatment of Lateral Epicondylalgia
University of Alcala
50 participants
Mar 12, 2025
INTERVENTIONAL
Conditions
Summary
Lateral epicondylalgia (LET) is characterized by pain, decreased muscle strength of the wrist extensor muscles, and disability. Among the treatments proposed in the literature, both focal shockwave therapy and radial shockwave therapy have been considered effective in the management of this musculoskeletal disorder. The objective of this study is to compare the safety and effectiveness of these two shockwave applications on the signs and symptoms of subjects with lateral epicondylalgia. In this clinical trial, subjects will be evaluated for elbow pain using a Visual Analog Scale (VAS), grip strength using a handheld dynamometer, and degree of disability using the Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE). A six-month follow-up will be performed. Patients will be randomly divided into three groups. The first group will receive radial shock waves (rESWT), the second group will receive focal shock waves (fESWT), and the third group, which will act as a control, will receive a placebo treatment with very low energy parameters according to the literature. Subjects will receive three sessions, one session per week.
Eligibility
Inclusion Criteria4
- Pain in the lateral epicondyle >3 months
- Pain when performing resisted grip
- Positive Cozen test
- Positive Maudsley test
Exclusion Criteria4
- Pregnancy
- Systemic diseases (Fibromyalgia, Diabetes, Arthritis)
- Local infection or Cancer
- Recent treatments (Physiotherapy, Corticosteroids)-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects in this group will receive radial shock waves
Subjects in this group will receive focal shock waves
Subjects in this group will receive a shock waves placebo treatment with very low energy settings
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06587412